• Live Feeds
    • Press Releases
    • Insider Trading
    • FDA Approvals
    • Analyst Ratings
    • Insider Trading
    • SEC filings
    • Market insights
  • Analyst Ratings
  • Alerts
  • Subscriptions
  • Settings
  • RSS Feeds
Quantisnow Logo
  • Live Feeds
    • Press Releases
    • Insider Trading
    • FDA Approvals
    • Analyst Ratings
    • Insider Trading
    • SEC filings
    • Market insights
  • Analyst Ratings
  • Alerts
  • Subscriptions
  • Settings
  • RSS Feeds
PublishGo to App
    Quantisnow Logo

    © 2025 quantisnow.com
    Democratizing insights since 2022

    Services
    Live news feedsRSS FeedsAlertsPublish with Us
    Company
    AboutQuantisnow PlusContactJobsAI superconnector for talent & startupsNEWLLM Arena
    Legal
    Terms of usePrivacy policyCookie policy

    SEC Form 144 filed by DocGo Inc.

    12/15/25 5:06:59 PM ET
    $DCGO
    Medical/Nursing Services
    Health Care
    Get the next $DCGO alert in real time by email
    Form 144 Filer Information UNITED STATES
    SECURITIES AND EXCHANGE COMMISSION
    Washington, D.C. 20549

    Form 144

    NOTICE OF PROPOSED SALE OF SECURITIES
    PURSUANT TO RULE 144 UNDER THE SECURITIES ACT OF 1933

    FORM 144

    144: Filer Information

    Filer CIK
    0001331867
    Filer CCC
    XXXXXXXX
    Is this a LIVE or TEST Filing? Radio button checked LIVE Radio button not checked TEST

    Submission Contact Information

    Name
    Phone
    E-Mail Address

    144: Issuer Information

    Name of Issuer
    DocGo Inc.
    SEC File Number
    001-39618
    Address of Issuer
    35 West 35th Street, Floor 6
    New York
    NEW YORK
    10001
    Phone
    8444436246
    Name of Person for Whose Account the Securities are To Be Sold
    Ely D Tendler
    See the definition of "person" in paragraph (a) of Rule 144. Information is to be given not only as to the person for whose account the securities are to be sold but also as to all other persons included in that definition. In addition, information shall be given as to sales by all persons whose sales are required by paragraph (e) of Rule 144 to be aggregated with sales for the account of the person filing this notice.

    Relationship to Issuer
    Director

    144: Securities Information

    Title of the Class of Securities To Be SoldName and Address of the BrokerNumber of Shares or Other Units To Be SoldAggregate Market ValueNumber of Shares or Other Units OutstandingApproximate Date of SaleName the Securities Exchange
    Common
    UBS Financial Services Inc
    1000 Harbor Blvd
    3rd Floor
    Weehawken � NJ � 07086
    1685015381.559781000012/15/2025
    NASDAQ


    Furnish the following information with respect to the acquisition of the securities to be sold and with respect to the payment of all or any part of the purchase price or other consideration therefor:

    144: Securities To Be Sold

    Title of the ClassDate you AcquiredNature of Acquisition TransactionName of Person from Whom AcquiredIs this a Gift?Date Donor AcquiredAmount of Securities AcquiredDate of PaymentNature of Payment *
    Common12/12/2024Vested Restricted StockDocGo IncCheckbox not checked3580012/12/2024Vested Restricted Stock

    * If the securities were purchased and full payment therefor was not made in cash at the time of purchase, explain in the table or in a note thereto the nature of the consideration given. If the consideration consisted of any note or other obligation, or if payment was made in installments describe the arrangement and state when the note or other obligation was discharged in full or the last installment paid.



    Furnish the following information as to all securities of the issuer sold during the past 3 months by the person for whose account the securities are to be sold.

    144: Securities Sold During The Past 3 Months

    Nothing to ReportCheckbox checked

    144: Remarks and Signature

    Remarks
    Client did not pay for shares
    Date of Notice
    12/15/2025

    ATTENTION:

    The person for whose account the securities to which this notice relates are to be sold hereby represents by signing this notice that he does not know any material adverse information in regard to the current and prospective operations of the Issuer of the securities to be sold which has not been publicly disclosed. If such person has adopted a written trading plan or given trading instructions to satisfy Rule 10b5-1 under the Exchange Act, by signing the form and indicating the date that the plan was adopted or the instruction given, that person makes such representation as of the plan adoption or instruction date.
    Signature
    /s/Mijo Suric, for UBS Financial Services Inc, as attorney-in-fact for Ely D Tendler

    ATTENTION: Intentional misstatements or omission of facts constitute Federal Criminal Violations (See 18 U.S.C. 1001)

    Get the next $DCGO alert in real time by email

    Crush Q1 2026 with the Best AI Superconnector

    Stay ahead of the competition with Standout.work - your AI-powered talent-to-startup matching platform.

    AI-Powered Inbox
    Context-aware email replies
    Strategic Decision Support
    Get Started with Standout.work

    Recent Analyst Ratings for
    $DCGO

    DatePrice TargetRatingAnalyst
    5/9/2025Buy → Neutral
    BTIG Research
    2/28/2025$5.00 → $2.85Buy → Hold
    Deutsche Bank
    8/18/2023$15.00Buy
    BTIG Research
    4/21/2023$11.00Overweight
    Cantor Fitzgerald
    4/19/2022$11.00Buy
    Deutsche Bank
    1/19/2022$14.00Buy
    Stifel
    12/21/2021$13.00Buy
    Canaccord Genuity
    12/7/2021$14.00Buy
    Needham
    More analyst ratings

    $DCGO
    Insider Purchases

    Insider purchases reveal critical bullish sentiment about the company from key stakeholders. See them live in this feed.

    View All

    Director Burdiek Michael J bought $13,300 worth of shares (10,000 units at $1.33), increasing direct ownership by 2% to 641,560 units (SEC Form 4)

    4 - DocGo Inc. (0001822359) (Issuer)

    5/23/25 4:25:30 PM ET
    $DCGO
    Medical/Nursing Services
    Health Care

    Director Burdiek Michael J bought $21,450 worth of shares (15,000 units at $1.43), increasing direct ownership by 2% to 631,560 units (SEC Form 4)

    4 - DocGo Inc. (0001822359) (Issuer)

    5/15/25 5:05:47 PM ET
    $DCGO
    Medical/Nursing Services
    Health Care

    Director Klasko Stephen K. M.D. bought $22,350 worth of shares (15,000 units at $1.49) (SEC Form 4)

    4 - DocGo Inc. (0001822359) (Issuer)

    5/14/25 5:42:40 PM ET
    $DCGO
    Medical/Nursing Services
    Health Care

    $DCGO
    Press Releases

    Fastest customizable press release news feed in the world

    View All

    DocGo Announces Participation at Upcoming December Investor Conferences

    DocGo Inc. (NASDAQ:DCGO) ("DocGo"), a leading provider of technology-enabled mobile health and medical transportation services, announced today that management will be participating in the following investor conferences in December: Noble Capital Markets Emerging Growth Conference (December 3rd) Lee Bienstock, Chief Executive Officer will participate in 1x1 meetings and deliver a presentation on Wednesday, December 3rd at 1:00 PM ET. A webcast of the event will be available on the investor relations section of DocGo's website at https://ir.docgo.com/. Citi's 2025 Global Healthcare Conference (December 4th) Lee Bienstock, Chief Executive Officer will participate in 1x1 meetings at this eve

    11/26/25 7:35:00 AM ET
    $DCGO
    Medical/Nursing Services
    Health Care

    DocGo Announces Participation at Upcoming Investor Conferences

    DocGo Inc. (NASDAQ:DCGO) ("DocGo"), a leading provider of technology-enabled mobile health and medical transportation services, announced today that management will be participating in the following investor conferences in November: 17th Annual Southwest Ideas Conference (November 19th) Norm Rosenberg, Chief Financial Officer will participate in 1x1 meetings and deliver a presentation on Wednesday November 19th at 2:20 PM ET. A webcast of the event will be available on the investor relations section of DocGo's website at https://ir.docgo.com/. Canaccord Genuity Medtech, Diagnostics and Digital Health & Services Forum (November 20st) Lee Bienstock, Chief Executive Officer, and Norm Rosen

    11/13/25 7:35:00 AM ET
    $DCGO
    Medical/Nursing Services
    Health Care

    DocGo Announces Third Quarter 2025 Results

    Company Achieves Record Volumes Across All Major Business Lines Management to Host Conference Call and Webcast Today at 5:00 PM Eastern Time DocGo Inc. (NASDAQ:DCGO) ("DocGo" or the "Company"), a leading provider of technology-enabled mobile health and medical transportation services, today announced financial and operating results for the quarter ended September 30, 2025. Third Quarter 2025 Financial Highlights Total revenue for the third quarter of 2025 was $70.8 million, compared to $138.7 million in the third quarter of 2024. This decline was entirely due to the wind-down of migrant-related programs, which generated $8.4 million in the third quarter of 2025 and $80.7 million in

    11/10/25 4:05:00 PM ET
    $DCGO
    Medical/Nursing Services
    Health Care

    $DCGO
    SEC Filings

    View All

    SEC Form 144 filed by DocGo Inc.

    144 - DocGo Inc. (0001822359) (Subject)

    12/15/25 5:06:59 PM ET
    $DCGO
    Medical/Nursing Services
    Health Care

    DocGo Inc. filed SEC Form 8-K: Regulation FD Disclosure

    8-K - DocGo Inc. (0001822359) (Filer)

    12/12/25 4:08:48 PM ET
    $DCGO
    Medical/Nursing Services
    Health Care

    SEC Form 10-Q filed by DocGo Inc.

    10-Q - DocGo Inc. (0001822359) (Filer)

    11/10/25 4:39:05 PM ET
    $DCGO
    Medical/Nursing Services
    Health Care

    $DCGO
    Insider Trading

    Insider transactions reveal critical sentiment about the company from key stakeholders. See them live in this feed.

    View All

    Chief Executive Officer Bienstock Lee was granted 1,113,495 shares and covered exercise/tax liability with 214,131 shares, increasing direct ownership by 46% to 2,836,281 units (SEC Form 4)

    4 - DocGo Inc. (0001822359) (Issuer)

    12/16/25 5:42:25 PM ET
    $DCGO
    Medical/Nursing Services
    Health Care

    CFO and Treasurer Rosenberg Norman was granted 429,405 shares and covered exercise/tax liability with 65,774 shares, increasing direct ownership by 42% to 1,223,571 units (SEC Form 4)

    4 - DocGo Inc. (0001822359) (Issuer)

    12/16/25 4:16:49 PM ET
    $DCGO
    Medical/Nursing Services
    Health Care

    Chief Compliance Officer Sugrue Stephen was granted 321,055 shares and covered exercise/tax liability with 35,968 shares, increasing direct ownership by 81% to 636,602 units (SEC Form 4)

    4 - DocGo Inc. (0001822359) (Issuer)

    12/16/25 4:14:00 PM ET
    $DCGO
    Medical/Nursing Services
    Health Care

    $DCGO
    Analyst Ratings

    Analyst ratings in real time. Analyst ratings have a very high impact on the underlying stock. See them live in this feed.

    View All

    DocGo downgraded by BTIG Research

    BTIG Research downgraded DocGo from Buy to Neutral

    5/9/25 8:41:42 AM ET
    $DCGO
    Medical/Nursing Services
    Health Care

    DocGo downgraded by Deutsche Bank with a new price target

    Deutsche Bank downgraded DocGo from Buy to Hold and set a new price target of $2.85 from $5.00 previously

    2/28/25 8:51:46 AM ET
    $DCGO
    Medical/Nursing Services
    Health Care

    BTIG Research initiated coverage on DocGo with a new price target

    BTIG Research initiated coverage of DocGo with a rating of Buy and set a new price target of $15.00

    8/18/23 7:24:03 AM ET
    $DCGO
    Medical/Nursing Services
    Health Care

    $DCGO
    Leadership Updates

    Live Leadership Updates

    View All

    DocGo Acquires PTI Health To Expand Proactive Healthcare Offering with Mobile Lab Collection and Mobile Phlebotomy Services

    DocGo Inc. (NASDAQ:DCGO) ("DocGo" or the "Company"), a leading provider of technology-enabled mobile health services, today announced the acquisition of PTI Health, a mid-Atlantic mobile lab collection and phlebotomy services company. This strategic move expands DocGo's healthcare service offering to include mobile phlebotomy lab services, addressing critical gaps in diagnostic care for underserved populations. With this acquisition, DocGo will facilitate timely, convenient blood collection and additional at-home testing services for patients, offering a new level of care to those with limited access to traditional labs or transportation options. The acquisition enhances DocGo's offerings

    2/10/25 7:35:00 AM ET
    $DCGO
    Medical/Nursing Services
    Health Care

    DocGo Appoints Healthcare Visionary Dr. Stephen K. Klasko as Chair of the Board

    DocGo Inc. (NASDAQ:DCGO) ("DocGo" or the "Company"), a leading provider of technology-enabled mobile health services, today announced the appointment of Stephen K. Klasko, M.D., M.B.A as the new independent, non-executive Chair of its Board of Directors, effective October 1, 2024. Dr. Klasko has an extensive background in leadership roles within healthcare, higher education and medical industry innovation, including an eight-year tenure as the President of Thomas Jefferson University and the CEO of Jefferson Health where he oversaw its expansion to 18 hospitals and over 35,000 employees. Prior to that, he was CEO of USF Health and Dean of the Morsani College of Medicine at the University o

    9/30/24 7:35:00 AM ET
    $DCGO
    Medical/Nursing Services
    Health Care

    DocGo Appoints Eiwe Lingefors as New Chief Information Officer

    DocGo Inc. (NASDAQ:DCGO) ("DocGo" or the "Company"), a leading provider of technology-driven healthcare solutions, is proud to announce Eiwe Lingefors as Chief Information Officer (CIO). Lingefors most recently served as the company's Chief Information Security Officer, and will continue in this role as well. In his new role as CIO, Lingefors will lead both DocGo's information security and digital innovation strategy in an evolving cybersecurity landscape. "Eiwe has been a vital part of our team, and his deep expertise in the security landscape has been instrumental in DocGo's operations," said Lee Bienstock, CEO of DocGo. "He has done an excellent job strengthening DocGo's existing cybers

    9/26/24 7:35:00 AM ET
    $DCGO
    Medical/Nursing Services
    Health Care

    $DCGO
    Financials

    Live finance-specific insights

    View All

    DocGo Announces Third Quarter 2025 Results

    Company Achieves Record Volumes Across All Major Business Lines Management to Host Conference Call and Webcast Today at 5:00 PM Eastern Time DocGo Inc. (NASDAQ:DCGO) ("DocGo" or the "Company"), a leading provider of technology-enabled mobile health and medical transportation services, today announced financial and operating results for the quarter ended September 30, 2025. Third Quarter 2025 Financial Highlights Total revenue for the third quarter of 2025 was $70.8 million, compared to $138.7 million in the third quarter of 2024. This decline was entirely due to the wind-down of migrant-related programs, which generated $8.4 million in the third quarter of 2025 and $80.7 million in

    11/10/25 4:05:00 PM ET
    $DCGO
    Medical/Nursing Services
    Health Care

    DocGo to Announce Third Quarter 2025 Results on Monday, November 10, 2025

    Management to host conference call and webcast at 5:00 p.m. ET on that day DocGo Inc. (NASDAQ:DCGO) ("DocGo" or the "Company"), a leading provider of technology-enabled mobile health and medical transportation services, announced today that the Company will release its financial results for the third quarter ended September 30, 2025 after the markets close on Monday, November 10, 2025. Management will also host a conference call to discuss these results at 5:00 p.m. ET on that day. Conference call and webcast details: Monday, November 10, 2025 5:00 p.m. ET 1-800-717-1738 (U.S.) 1-646-307-1865 (international) Conference ID: 87106 To access the Call me™ feature, which avoids the nee

    10/27/25 7:35:00 AM ET
    $DCGO
    Medical/Nursing Services
    Health Care

    DocGo Acquires Virtual Care Platform SteadyMD, Expands Telehealth Services Across All 50 States

    Strategic Acquisition Combines DocGo's Last Mile Healthcare Delivery Capabilities With SteadyMD's Virtual Care Platform; SteadyMD Is Expected To Generate Approximately $25 Million in Revenue in 2025* DocGo Inc. (NASDAQ:DCGO) ("DocGo" or the "Company"), a leading provider of technology-enabled mobile health and medical transportation services, today announced that it has acquired virtual care platform SteadyMD, Inc. Management will host a conference call and webcast on Tuesday, October 21 at 11:00 a.m. ET to discuss this acquisition. SteadyMD powers high-quality telehealth experiences for digital health companies, labs, pharmacies, employers, and other healthcare innovators. The company

    10/20/25 5:21:00 PM ET
    $DCGO
    Medical/Nursing Services
    Health Care

    $DCGO
    Large Ownership Changes

    This live feed shows all institutional transactions in real time.

    View All

    Amendment: SEC Form SC 13D/A filed by DocGo Inc.

    SC 13D/A - DocGo Inc. (0001822359) (Subject)

    11/29/24 4:14:57 PM ET
    $DCGO
    Medical/Nursing Services
    Health Care

    Amendment: SEC Form SC 13G/A filed by DocGo Inc.

    SC 13G/A - DocGo Inc. (0001822359) (Subject)

    11/14/24 9:56:36 AM ET
    $DCGO
    Medical/Nursing Services
    Health Care

    SEC Form SC 13G/A filed by DocGo Inc. (Amendment)

    SC 13G/A - DocGo Inc. (0001822359) (Subject)

    3/1/24 4:53:15 PM ET
    $DCGO
    Medical/Nursing Services
    Health Care